U.K. watchdogs push India's Wockhardt to recall 5 drugs

U.K. regulators have changed their mind about the need for a Wockhardt recall. The Medicines and Healthcare products Regulatory Agency (MHRA) asked Indian drugmaker Wockhardt to pull a handful of drugs manufactured at its troubled Chikalthana facility. Earlier this week, the agency banned the company from exporting most of its drugs to Europe, but said no drugs were being recalled. Report

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.